U.S. officials from the Trump administration recently pressured Germany to pay higher prices for medicines, according to a person familiar with the discussions. The demand was conveyed to the German ambassador to the United States during a recent meeting.
This development comes as a political contest in the United Kingdom threatens to further unsettle global drug pricing policies. The outcome of this contest could have far-reaching implications for pharmaceutical markets worldwide.
For more insights into the science and politics shaping biotech today, sign up for our biotech newsletter.
Related articles
Kennedy Swaps Vaccine Rhetoric for Story Time but Can’t Quite Change the Subject
Here in Washington, we’ve been hearing about tensions between the White House and one of its most controversial — but, at least in some circles, most...
STAT+: Pharmalittle: We’re reading about U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and more
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about we...
FDA Blocked Melanoma Drug as Confusion Reigned Under Makary
The FDA’s recent decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who treat melanoma and patients who saw th...
STAT+: Top U.S. officials pressured Germany to pay more for prescription drugs
WASHINGTON — Over a recent breakfast, U.S. officials had a message for the German ambassador: pay more for pharmaceuticals. The meeting, between U.S....
Opinion: I’m 73. I wish my pills wouldn’t keep changing colors and shapes
At the ripe old age of 73, I take six drugs — four prescription and two over-the-counter pills — every day. I keep careful track of them. But recently...
Makary’s departure and Cassidy’s tenuous Senate seat
This week’s episode of “The Readout LOUD” is all about health politics. We bring on FDA reporter Lizzy Lawrence to discuss Makary’s departure — why he...
STAT investigates the epidemic killing 178,000 Americans a year
Dear Readers, I want to bring your attention to “The Deadliest Drug,” a new STAT investigative series about our nation’s failure to address excessive...
STAT+: The hunt for FDA’s next leader
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to...